MedPath

Concordia Pharmaceuticals Inc.

🇱🇺Luxembourg
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

FDA:13

Drug Approvals

Orapred

Approval Date
Jun 3, 2025
FDA

Plaquenil

Approval Date
Dec 20, 2023
FDA

Zonegran

Approval Date
Nov 17, 2023
FDA

Dibenzyline

Approval Date
Jul 3, 2023
FDA

Dyrenium

Approval Date
Jul 3, 2023
FDA

Donnatal

Approval Date
Jan 10, 2023
FDA

Donnatal

Approval Date
Jan 10, 2023
FDA

Nilandron

Approval Date
Jul 8, 2022
FDA

LANOXIN

Approval Date
Apr 12, 2022
FDA

Salagen

Approval Date
Feb 11, 2022
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.